Candel Therapeutics
Price & Volume
Stats
See more52W Range | $4.19-$13.68 |
Market Cap | $253.6M |
Shares Short | 7M |
Financials
See moreRevenue (12 Mos) | $31,000 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | -$23M |
Diluted EPS | -$0.56 |
News
See moreYahoo Finance • 3 days ago
Candel Therapeutics to Host Virtual R&D Event on December 5, 2025
Yahoo Finance • 6 days ago
Candel pausing development of CAN-2409 in prostate cancer type
Yahoo Finance • 7 days ago
Candel Therapeutics Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights
Yahoo Finance • 17 days ago
Candel Therapeutics to Present at Jefferies Global Healthcare Conference in London
About
CEO | Dr. Paul-Peter Tak FOCIS, M.D., Ph.D. |
CFO | Mr. Charles Schoch |
Address | 117 Kendrick Street, Needham, MA, United States, 02494 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 38 |
